Leveraging linked registry and electronic health records to examine long-term patient outcomes after peripheral vascular intervention"

利用关联的登记和电子健康记录来检查外周血管介入治疗后患者的长期结果”

基本信息

  • 批准号:
    10676773
  • 负责人:
  • 金额:
    $ 16.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

Leveraging linked registry and electronic health records to examine long-term patient outcomes after peripheral vascular intervention Project Summary/Abstract Peripheral arterial disease (PAD) affects over 200 million people worldwide. Peripheral vascular interventions (PVI) are the most common procedures that are performed to manage PAD. Existing randomized controlled trials (RCTs) and observational studies of patient outcomes after PVIs all had limited follow-up lengths due to difficulties in long-term data collections. In addition, heterogeneity of treatment effect (HTE) for stent placement vs. percutaneous transluminal angioplasty (PTA) alone has not been well understood with the current approach of effect modifier assessment. Real-world data (RWD), particularly registries linked with electronic health data (EHR), are useful for studying long-term outcomes after vascular procedures. However, methods for working with multiple data sources and analyzing unstructured text data are still evolving. The proposed research aims to address current evidence gaps in long-term patient outcomes after PVI procedures. This will be facilitated by innovatively apply and refine data linkage, natural language processing (NLP), and effect modifier assessment methods. Specifically, this project will link registry and EHR data to 1) examine long-term major adverse limb events after stent placement vs. PTA alone as well as assess heterogeneity of treatment effect by patient characteristics; 2) develop an NLP pipeline with machine learning methods to analyze unstructured text data and examine long-term efficacy endpoints after stent placement vs. PTA alone, and; 3) establish feasibility and updating requirements for the deployment of the NLP tool for long-term PVI outcome assessment to other institutions. To support the research activities and the transition toward independence, the candidate will undertake the following career development activities during the award period: 1) gaining an in- depth understanding of NLP and machine learning methods; 2) refining data science expertise to integrate EHR into medical device epidemiologic research; 3) strengthening knowledge in current and novel vascular disease treatment; 4) developing and improving skills in grant writing and academic leadership; 5) training in responsible conduct of research. The candidate will be mentored by a team of experts with complementary strengths in surgical and device outcomes research, natural language processing and machine learning, and vascular disease and surgery. The proposed career development and research activities will develop the candidate's skillset and expertise and lead to an R01 level application. The candidate's long-term goal is to become an independent researcher focusing on the development and application of advanced multidisciplinary methods in the evaluation of surgical and device outcomes in the vascular disease area, supporting clinical, patient, and regulatory decision-making.
利用链接的注册表和电子健康记录来检查患者的长期结果

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Longer patient travel distance is associated with increased non-index readmission after complex aortic surgery.
较长的患者移动距离与复杂主动脉手术后非指数再入院的增加有关。
  • DOI:
    10.1016/j.jvs.2023.02.005
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    4.3
  • 作者:
    Feldman,ZachM;Zheng,Xinyan;Mao,Jialin;Sumpio,BrandonJ;Mohebali,Jahan;Chang,DavidC;Goodney,PhilipP;Conrad,MarkF;Srivastava,SunitaD
  • 通讯作者:
    Srivastava,SunitaD
Greater Patient Travel Distance is Associated with Perioperative and One-Year Cost Increases After Complex Aortic Surgery.
患者移动距离较长与复杂主动脉手术后围手术期和一年费用的增加有关。
  • DOI:
    10.1016/j.avsg.2023.05.040
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    1.5
  • 作者:
    Feldman,ZachM;Zheng,Xinyan;Mao,Jialin;Sumpio,BrandonJ;Mohebali,Jahan;Chang,DavidC;Goodney,PhilipP;Srivastava,SunitaD;Conrad,MarkF
  • 通讯作者:
    Conrad,MarkF
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jialin Mao其他文献

Jialin Mao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jialin Mao', 18)}}的其他基金

Leveraging linked registry and electronic health records to examine long-term patient outcomes after peripheral vascular intervention"
利用关联的登记和电子健康记录来检查外周血管介入治疗后患者的长期结果”
  • 批准号:
    10463785
  • 财政年份:
    2021
  • 资助金额:
    $ 16.25万
  • 项目类别:
Leveraging linked registry and electronic health records to examine long-term patient outcomes after peripheral vascular intervention"
利用关联的登记和电子健康记录来检查外周血管介入治疗后患者的长期结果”
  • 批准号:
    10283367
  • 财政年份:
    2021
  • 资助金额:
    $ 16.25万
  • 项目类别:

相似海外基金

Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10707830
  • 财政年份:
    2023
  • 资助金额:
    $ 16.25万
  • 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
  • 批准号:
    479728
  • 财政年份:
    2023
  • 资助金额:
    $ 16.25万
  • 项目类别:
    Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
  • 批准号:
    10884567
  • 财政年份:
    2023
  • 资助金额:
    $ 16.25万
  • 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
  • 批准号:
    10751964
  • 财政年份:
    2023
  • 资助金额:
    $ 16.25万
  • 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
  • 批准号:
    486321
  • 财政年份:
    2022
  • 资助金额:
    $ 16.25万
  • 项目类别:
    Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10676786
  • 财政年份:
    2022
  • 资助金额:
    $ 16.25万
  • 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10440970
  • 财政年份:
    2022
  • 资助金额:
    $ 16.25万
  • 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
  • 批准号:
    10642998
  • 财政年份:
    2022
  • 资助金额:
    $ 16.25万
  • 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10482465
  • 财政年份:
    2022
  • 资助金额:
    $ 16.25万
  • 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
  • 批准号:
    10191053
  • 财政年份:
    2020
  • 资助金额:
    $ 16.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了